Evidence map›Paper›PMID 30682324›Full record

ArticleSLAS discovery : advancing life sciences R & D2019

Integrated Multiparametric High-Content Profiling of Endothelial Cells.

Erika Wiseman, Annj Zamuner, Zuming Tang, James Rogers, Sabrina Munir, Lucy Di Silvio, Davide Danovi, Lorenzo Veschini

Abstract read
In one paragraph

Article in SLAS discovery : advancing life sciences R & D, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The Academic Pill: How Academia Contributes to Curing Diseases.SLAS discovery : advancing life sciences R & D · 2019
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Erika Wiseman1 Stem Cell Hotel-Cell Phenotyping Platform, Centre for Stem Cells & Regenerative Medicine, King's College London, London, UK.
Annj Zamuner3 Tissue Engineering & Biophotonics, Dental Institute, King's College London, London, UK.
Zuming Tang1 Stem Cell Hotel-Cell Phenotyping Platform, Centre for Stem Cells & Regenerative Medicine, King's College London, London, UK.
James Rogers3 Tissue Engineering & Biophotonics, Dental Institute, King's College London, London, UK.
Sabrina Munir1 Stem Cell Hotel-Cell Phenotyping Platform, Centre for Stem Cells & Regenerative Medicine, King's College London, London, UK.
Lucy Di Silvio3 Tissue Engineering & Biophotonics, Dental Institute, King's College London, London, UK.
Davide Danovi1 Stem Cell Hotel-Cell Phenotyping Platform, Centre for Stem Cells & Regenerative Medicine, King's College London, London, UK.ORCID 0000-0003-4119-5337
Lorenzo Veschini3 Tissue Engineering & Biophotonics, Dental Institute, King's College London, London, UK.

Funding

Medical Research CouncilWellcome TrustWellcome Trust WT098503
6 · The paper itself

Abstract

Endothelial cells (ECs) are widely heterogeneous at the cell level and serve different functions at the vessel and tissue levels. EC-forming colonies derived from induced pluripotent stem cells (iPSC-ECFCs) alongside models such as primary human umbilical vein ECs (HUVECs) are slowly becoming available for research with future applications in cell therapies, disease modeling, and drug discovery. We and others previously described high-content analysis approaches capturing unbiased morphology-based measurements coupled with immunofluorescence and used these for multidimensional reduction and population analysis. Here, we report a tailored workflow to characterize ECs. We acquire images at high resolution with high-magnification water-immersion objectives with Hoechst, vascular endothelial cadherin (VEC), and activated NOTCH staining. We hypothesize that via these key markers alone we would be able to distinguish and assess different EC populations. We used cell population software analysis to phenotype HUVECs and iPSC-ECFCs in the absence or presence of vascular endothelial growth factor (VEGF). To our knowledge, this study presents the first parallel quantitative high-content multiparametric profiling of EC models. Importantly, it highlights a simple strategy to benchmark ECs in different conditions and develop new approaches for biological research and translational applications for regenerative medicine.

Indexed as

BiomarkersCadherinsEndothelium, VascularHumansHuman Umbilical Vein Endothelial CellsInduced Pluripotent Stem CellsReceptors, NotchVascular Endothelial Growth Factor ABiomarkersCadherinsReceptors, NotchVascular Endothelial Growth Factor Aendothelial cellshigh-content analysisiPSphenotypingstem cells

Identifiers

PMID30682324
PMCPMC6484530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.